Skip to content

AEOLUS PHARMACEUTICALS, INC.

CIK 0001261734

← back to feed
Revenue (TTM)
$1.4K
−3.4% YoY Q3 Aug 2017
Net Income (TTM)
−$3.94M
−35.4% YoY Q3 Aug 2017
EPS Diluted (TTM)
−$0.04
−100.0% YoY Q3 Aug 2017
Gross Margin
—
Q3 Aug 2017
Operating Margin
-281,844.2%
Q3 Aug 2017
Net Margin
-281,844.2%
Q3 Aug 2017
Free Cash Flow (TTM)
−$3.49M
Q3 Aug 2017
Cash
$403K
Q3 Aug 2017
Total Debt
$0
Q3 Aug 2017
Shares Outstanding
152.09M sh
Q3 Aug 2017

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings